129 related articles for article (PubMed ID: 27403255)
21. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
22. Desferrioxamine and dextromethorphan combination exhibited synergistic effect and reversed the catalepsy behaviour in 6-hydroxydopamine hydroydopamine administered rats through regulating brain glutamate levels.
Mannan Thodukayil N; Antony J; Thomas P; Jeyarani V; Choephel T; Manisha C; Jose A; Karolina Sahadevan S; Kannan E
J Pharm Pharmacol; 2019 Aug; 71(8):1271-1281. PubMed ID: 31144300
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
24. Activation and blockade of serotonin
Guo Y; Zhang L; Zhang J; Du CX; Lv SX; Wang T; Wang HS; Xie W; Liu J
Neurol Res; 2019 Jul; 41(7):585-593. PubMed ID: 30929589
[No Abstract] [Full Text] [Related]
25. 6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase.
Kunikowska G; Jenner P
Brain Res; 2001 Dec; 922(1):51-64. PubMed ID: 11730701
[TBL] [Abstract][Full Text] [Related]
26. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
[TBL] [Abstract][Full Text] [Related]
27. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
Kumari R; Kumar JB; Luthra PM
Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406
[TBL] [Abstract][Full Text] [Related]
28. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of betulinic acid effects on pain, memory, anxiety, catalepsy, and oxidative stress in animal model of Parkinson's disease.
Abrishamdar M; Farbood Y; Sarkaki A; Rashno M; Badavi M
Metab Brain Dis; 2023 Feb; 38(2):467-482. PubMed ID: 35708868
[TBL] [Abstract][Full Text] [Related]
30. Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats.
Sharifi H; Mohajjel Nayebi A; Farajnia S; Haddadi R
Adv Pharm Bull; 2015 Nov; 5(4):491-5. PubMed ID: 26819921
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
32. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
33. The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson's disease.
Wąsik A; Polak D; Romańska I; Michaluk J; Antkiewicz-Michaluk L
Pharmacol Rep; 2016 Dec; 68(6):1205-1213. PubMed ID: 27657483
[TBL] [Abstract][Full Text] [Related]
34. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
35. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
[TBL] [Abstract][Full Text] [Related]
36. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
[TBL] [Abstract][Full Text] [Related]
37. The selective 5-HT(1A) receptor antagonist WAY-100635 increases neuronal activity of the basolateral nucleus of the amygdala in 6-hydroxydopamine-lesioned rats.
Zhang QJ; Wu ZH; Liu J; Wang T; Wang S; Han LN
Sheng Li Xue Bao; 2008 Apr; 60(2):259-69. PubMed ID: 18425316
[TBL] [Abstract][Full Text] [Related]
38. Effect of cerebral dopamine neurotrophic factor on endogenous neural progenitor cell migration in a rat model of Parkinson's disease.
Nasrolahi A; Mahmoudi J; Karimipour M; Akbarzadeh A; Sadigh-Eteghad S; Salehi R; Farajdokht F; Farhoudi M
EXCLI J; 2019; 18():139-153. PubMed ID: 30956647
[TBL] [Abstract][Full Text] [Related]
39. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
[TBL] [Abstract][Full Text] [Related]
40. Pilose Antler Extracts (PAEs) Protect against Neurodegeneration in 6-OHDA-Induced Parkinson's Disease Rat Models.
Li C; Sun Y; Yang W; Ma S; Zhang L; Zhao J; Zhao X; Wang Y
Evid Based Complement Alternat Med; 2019; 2019():7276407. PubMed ID: 30728849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]